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Abstract
Background: The non-pathogenic course of SIV infection in its natural host is characterized by robust viral
replication in the absence of chronic immune activation and T cell proliferation. In contrast, acutely lethal
enteropathic SIVsmm strain PBj induces a strong immune activation and causes a severe acute and lethal disease
in pig-tailed macaques after cross-species transmission. One important pathogenicity factor of the PBj virus is the
PBj-Nef protein, which contains a conserved diacidic motif and, unusually, an immunoreceptor tyrosine-based
activation motif (ITAM).
Results: Mutation of the diacidic motif in the Nef protein of the SIVsmmPBj abolishes the acute phenotype of this
virus. In vitro, wild-type and mutant PBj (PBj-Nef202/203GG) viruses replicated to similar levels in macaque PBMCs,
but PBj-Nef202/203GG no longer triggers ERK mitogen-activated protein (MAP) kinase pathway including an
alteration of a Nef-associated Raf-1/ERK-2 multiprotein signaling complex. Moreover, stimulation of IL-2 and down-
modulation of CD4 and CD28 were impaired in the mutant virus. Pig-tailed macaques infected with PBj-Nef202/
203GG did not show enteropathic complications and lethality as observed with wild-type PBj virus, despite efficient
replication of both viruses in vivo. Furthermore, PBj-Nef202/203GG infected animals revealed reduced T-cell
activation in periphery lymphoid organs and no detectable induction of IL-2 and IL-6.
Conclusions: In sum, we report here that mutation of the diacidic motif in the PBj-Nef protein abolishes disease
progression in pig-tailed macaques despite efficient replication. These data suggest that alterations in the ability of
a lentivirus to promote T cell activation and proliferation can have a dramatic impact on its pathogenic potential.
Background
Human and some simian immunodeficiency viruses
(HIV, SIV) induce a slowly progressing immunodefi-
ciency disease, preceded by an acute phase occurring
within the first weeks of infection. The acute phase is
often characterized by fever, rash, leukopenia, diarrhea,
generalized lymphadenopathy, and anorexia associated
with a peak of viremia and antigenemia [1-3]. In the
early phase of infection, the gut-associated lymphoid tis-
sue (GALT) rapidly becomes an active and preferred
site of viral replication [4,5]. Primary viral replication in
the GALT virtually eradicates memory CD4+ T cells in
this compartment and is seen as a first strike of the
virus against the immune system with long-lasting
impacts [6-8]. While depletion of the GALT seems to
be a common feature of lentiviral infections in primates
[4-10], only in symptomatic courses of infection does
the mucosal barrier become leaky resulting in transloca-
tion of microbial products and high levels of chronic
immune activation [11,12]. In contrast, during asympto-
matic infections the mucosal barrier recovers and the
chronic phase is characterized by robust viral replication
in the absence of immune activation [10,13]. However,
which viral or host factors tip the balance between
destruction or reconstitution of the mucosal barrier
remains elusive.
The SIV macaque model provides a system to study len-
tivirus host cell interactions especially in the acute phase
of infection and in the pathogenesis of acquired immuno-
deficiency syndrome (AIDS), mirroring especially the
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originally isolated from sooty mangabey monkeys (smm),
induces a severe acute and lethal disease in pig-tailed
macaques within 14 days of infection [15,16]. Character-
istic acute symptoms are dehydration, severe lymphope-
nia, cutaneous rash and hemorrhagic diarrhea [17].
Pathological alterations observed during this phase
include gastrointestinal villus blunting and fusion, mono-
nuclear cell infiltration within the gastrointestinal tract,
and high levels of virus replication in the GALT [18].
Similar pathological features, albeit in a milder form, are
commonly observed in human AIDS patients, referred to
as HIV enteropathy [4,19,20]. The severe acute patho-
genicity of PBj is linked to the ability of the virus to
induce activation and proliferation of infected resting
peripheral blood mononuclear cells (PBMCs), which is
associated with elevated levels of proinflammatory cyto-
kines [21,22], such as IL-6 and TNF-a [23].
Multiple genetic elements have been described that
influence the acutely lethal phenotype of PBj [24], and
particularly the viral accessory protein Nef has been
shown to play a critical role. An immunoreceptor tyro-
sine-based activation motif (ITAM) important for cell
activation processes, located at the amino-terminus of
Nef, has been described as one of the genetic determi-
nants of SIV-PBj pathogenicity [25,26]. When reconsti-
tuted in the nef gene of the pathogenic SIVmac239,
SIVsmmPBj-like features, as replication in resting
PBMCs accompanied with lymphocyte activation [27,28]
and induction of acute enteropathic pathogenesis
[27-29] in inoculated macaques, were recovered with the
respective mutated virus. However, while the reconstitu-
tion of the ITAM resulted in enhanced T cell activation
and viral replication, it is still unclear if the high patho-
genicity of this virus is mediated by its unusual ability to
boost immune activation. Moreover, when the ITAM is
transferred into an apathogenic lentivirus, its presence
alone in Nef seems not to be sufficient for induction of
acute pathogenicity [30,31].
The Nef protein is conserved in HIV and SIV and has
been shown to be required for high viral loads and
rapid progression to simian AIDS in infected rhesus
macaques [32]. In addition, it has been suggested that
loss of Nef´s ability to down-regulate CD3 and conse-
quently block T-cell activation might be one reason for
the high pathogenicity of HIV-1 in humans [33]. This
hypothesis is supported by recent data showing that
suppression of T- cell activation by Nef correlates with
preserved T-cell counts in naturally infected sooty man-
gabeys [34]. Expression of Nef causes downregulation of
a number of cell surface proteins, including CD4 [35],
CD3 [36,37], and major histocompatibility complex
(MHC) class I molecules [33,38]. Moreover, Nef modu-
lates intracellular signaling pathways including the
mitogen-activated protein kinase (MAPK) pathway via a
conserved D-D-X-X-X-E motif present in the external
loop region [39,40]. This evolutionary highly conserved
signaling pathway, consisting of Raf-1, MEK1/2 (MAPK/
ERK kinase) and the extracellular signal-regulated kinase
(ERK) 1/2, is critical for cellular proliferation and activa-
tion processes [41]. These processes are involved in bio-
logical responses such as secretion of IL-2 [42,43],
expression of cell activation markers such as CD69 and
CD25 [44], activation of nuclear factor-B( N F - B) [45],
up-regulation of lentiviral long terminal repeat (LTR)-
dependent transcription [46] or other steps in the lenti-
viral life cycle [47,48].
We report here that mutation of the D-D-X-X-X-E
motif in SIVsmmPBj-Nef (Nef202/203GG) leads to loss
of MAPK-pathway activation without affecting the Nef
protein’s ability to stimulate viral replication in macaque
PBMC. We exploited the unique phenotype of this
mutant to study the impact of lentivirus induced T-cell
activation and cellular proliferation. Pig-tailed macaques
infected with PBj-Nef202/203GG virus exhibited viral
loads similar to PBj-wt virus, while general immune
activation was reduced. Most strikingly, PBj-Nef202/
203GG virus infection did not show destruction of
GALT and lethality as observed with PBj-wt virus. Alto-
gether, the data presented here suggest a link between
the ability of a lentivirus to induce T-cell activation and
cellular proliferation with its ability to cause disease.
Results
Mutant PBj-Nef202/203GG virus shows similar replication
kinetics and protein expression levels as wild-type PBj
To interfere with Nef-induced modulation of MAPK
pathway, we introduced two nucleotide mutations into
the nef gene of the infectious molecular virus clone
SIVsmmPBj1.9, such that the two encoded consecutive
aspartate residues (D) within the conserved D202-D203-
X-X-X-E consensus motif in the C-terminal region of
PBj-Nef were mutated into glycines (G). The resulting
virus variant was termed PBj-Nef202/203GG (Figure
1A). The structural integrity of the mutant PBj virus
particles was verified by electron microscopy (data not
shown).
To examine the physiological consequences of this
mutation, we first infected PHA-stimulated and non-sti-
mulated PBMCs isolated from 6 different pig-tailed
macaque donors in vitro with PBj-wt and PBj-Nef202/
203GG using a multiplicity of infection (MOI) of 1.
Infection with a virus variant which does not express
Nef (PBj-ΔNef) was used as a control. Determination of
reverse transcriptase (RT) activity in cell culture super-
natants at different time-points after infection revealed
indistinguishable replication kinetics of PBj-wt and PBj-
Nef202/203GG in stimulated (Figure 1B) as well as in
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Page 2 of 17Figure 1 Construction and replication kinetics of PBj-wt and PBj-Nef202/203GG. (A) Schematic structure of SIV-PBj1.9 genome and PBj-Nef
protein. The position of the ITAM (YxxL), SH3-binding motif (PxxPxxP), start of the 3’ long terminal repeat (3’ LTR) and the D-D-X-X-X-E motif are
indicated. (B) or non-stimulated (C) primary macaque PBMCs from 6 animals were infected with the PBj-wt, PBj-Nef202/203GG or PBj-ΔNef virus
with an MOI of 1. RT activity was measured in culture supernatants. Error bars, SD. (D) Analysis of RT activity upon infection of non-stimulated
primary macaque PBMCs with serial dilutions of PBj-wt or PBj-Nef202/203GG virus. (E) Western blot detection of Nef protein expression in cell
lysates of uninfected, PBj-wt-, PBj-Nef202/203GG- and PBj-ΔNef-virus infected C8166 T cells at day 8 p.i. Protein expression of viral Gag, Vpx, Vpr
and cellular tubulin was analyzed as control.
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ΔNef replicated efficiently only in stimulated PBMCs
(Figure 1B and 1C). Since effects of Nef on viral replica-
tion are more manifest at low MOI, RT activity was
analyzed after infection of non-stimulated PBMCs using
different MOI. In each case, similar replication kinetics
of PBj-wt and PBj-Nef202/203GG were observed (Figure
1D). We next investigated whether the DD202/203GG
mutation changed the expression level of Nef. Western
blot analysis showed comparable Nef protein expression
in C8166 T cells infected with PBj-wt or mutant PBj-
Nef 202/203GG virus and, as expected, no detectable
Nef protein in PBj-ΔNef infected cells. Comparable
expression levels of viral Gag, Vpx and Vpr proteins as
well as cellular tubulin were demonstrated (Figure 1E).
Taken together, these results indicate that the intro-
duced mutation does not affect the Nef protein expres-
sion level and the efficiency of SIVsmmPBj replication
in activated and resting PBMC cultures.
PBj-Nef202/203GG does not induce cell proliferation and
activation of non-stimulated macaque PBMCs during
replication
Previous studies revealed that SIVsmmPBj is able to
replicate in non-stimulated, resting macaque PBMCs,
concomitantly activating and inducing the proliferation
of cells [16]. To analyze the replication and activation
profile of the virus mutant, we infected primary non-sti-
mulated PBMCs from 3 different macaque donors with
PBj-wt or PBj-Nef202/203GG viruses (MOI of 1). As
expected from the replication kinetics (Figure 1C), high
numbers of infected cells were detected by SIV immu-
nostaining in both cultures on day 5 and day 8 p.i. (Fig-
ure 2A). Quantification of the percentage of infected
cells among total cell numbers in the respective culture
on day 8 p.i. showed no significant difference between
cultures infected with PBj-wt virus or the mutated PBj-
Nef202/203GG virus, with a mean number of about 15%
or 12% of total cell numbers infected, respectively (Fig-
ure 2A). Thus, no impairment of virus replication by the
Nef-mutation could be observed, again. However, only
PBj-wt virus, but not PBj-Nef202/203GG, consistently
induced microscopically visible proliferation of PBMCs
as detected by typical cell clusters and raise in cell num-
bers. Therefore, cell proliferation was measured by
3H-
thymidine-incorporation on day 10 p.i. Consistent with
previous results by Fultz et al. [16], infection of non-sti-
mulated PBMCs with PBj-wt virus resulted in an 8.5-
fold increase in thymidine uptake compared to unin-
fected non-stimulated PBMCs (Figure 2B), indicating
the stimulation of cell proliferation by viral infection. In
contrast, infection of non-stimulated cells with PBj-
Nef202/203GG resulted only in a 2.4-fold enhanced
3H-
thymidine uptake. A 14.9-fold increase in
3H-thymidin-
incorporation was induced by control stimulation of
non-infected PBMCs with phytohemagglutinin (PHA)
and IL-2. These results indicate that PBj virus-induced
PBMC proliferation is strongly impaired by the absence
of the D-D-X-X-X-E motif in the Nef-protein.
Induction of cell proliferation requires mitogenic sig-
naling via the ERK-dependent signaling cascade. There-
fore, we analyzed the PBj virus-induced modulation of
ERK1/2 kinase activity in non-stimulated primary maca-
que-derived PBMCs after infection with PBj-wt and
mutant virus (MOI of 1) in an in vitro immuno-
complex kinase assay. No activation of ERK1/2 was
detected 30 minutes p.i. with either PBj virus, shown by
the absence of phosphorylation of the ERK1/2 substrate
ELK-1. However, a moderately increased ERK1/2 activ-
ity was observed on day 2 and 5 p.i. in PBj-wt infected
c e l l s( d a t an o ts h o w n ) ,a n do nd a y8p . i .as t r i k i n g
ERK1/2 activity was detected. In contrast, ERK1/2 activ-
ity was never observed in PBMCs infected with PBj-
Nef202/203GG virus or in uninfected cells (Figure 2C).
Thus, the D-D-X-X-X-E motif present in PBj-wt is
essential for sustained activation of ERK in infected
PBMCs.
As activation of the Raf-1-/MEK1/2-/ERK1/2 pathway
is able to activate NF-B, we analyzed the activity of
this transcription factor in PBMCs 10 days p.i. in elec-
trophoretic mobility shift assays (EMSA), monitoring
binding of NF-B p50/p65 extracted from infected cells
to a
32P-labeled NF-B specific probe. Infection of non-
stimulated macaque PBMCs with PBj-wt virus (MOI of
1) induced enhanced binding of NF-B p50/p65 hetero-
dimeric complexes to the probe, demonstrating NF-B
activation (Figure 2D). This enhanced binding of NF-B
was comparable, albeit less pronounced to that observed
in PHA/IL-2 stimulated cells. In contrast, infection with
PBj-Nef202/203GG virus did not induce NF-Ba c t i v a -
tion. Specific binding of heterodimeric NF-B-com-
plexes was confirmed by adding an excess of unlabeled
NF-B specific probe as a competitor (data not shown)
or by using NF-B-p50 and NF-B-p65 specific antibo-
dies in supershift experiments (Figure 2D).
These results indicate that the D-D-X-X-X-E motif in
SIVsmmPBj-Nef is critical for activation of Raf-1-/MEK1/
2-/ERK1/2- and NF-B- dependent signaling pathways.
To test the physical interaction of Nef via its D-D-X-X-X-
E motif with cellular Raf-1 in vitro as reported for HIV-1
[40], precipitation experiments were performed using
recombinant GST-PBj-Nef proteins. Surprisingly, both
recombinant Nef proteins precipitated Raf-1 (Figure 2E,
upper). However, ERK-2 was only precipitated efficiently
with GST-Nef-PBj-wt, suggesting that the D-D-X-X-X-E
motif is required for recruitment of ERK-2 into the Nef-
associated multiprotein signaling complex (Figure 2E, mid-
dle). Since the central proline-rich motif of HIV-Nef has
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Page 4 of 17Figure 2 Proliferation of PBMCs and activation of ERK1/2 and NF-B upon infection with PBj-wt or PBj-Nef202/203GG virus. (A) Analysis
of virus gene expression by in situ immunostaining of PBj-wt or PBj-Nef202/203GG virus infected cell cultures with bar chart showing the
percentage of infected cells at day 8 post infection as determined by cell counting. Magnification, 200 × (ns, P = 0.31). (B) Macaque PBMCs from
3 animals were infected with PBj-wt or PBj-Nef202/203GG virus. At day 10 p.i., cell proliferation was assessed by
3H-thymidine incorporation.
PHA/IL-2 stimulated as well as non-stimulated uninfected PBMCs served as controls. Error bars, SD (**, P < 0.04 compared to control; ***, P =
0.036; ns, P = 0.21). Numbers represent stimulation index compared to non-stimulated uninfected cells. (C) In vitro ERK1/2 kinase activity. Non-
stimulated macaque PBMCs were left untreated or infected with PBj-wt or PBj-Nef202/203GG virus. g-
32P-phosphorylation of ELK-1 quantified
ERK1/2-activity. Western blot detection of ERK-2 served as loading control. (D) EMSA of NF-B activation. Non-stimulated macaque PBMCs were
left untreated, stimulated by PHA/IL-2 or infected with PBj-wt or PBj-Nef202/203GG virus. On day 10 p.i., NF-B activity was assessed using a
specific
32P-labelled oligonucleotide. The specificity of NF-B binding complexes was confirmed by using NF-B-p50 and NF-B-p65 specific
antibodies in supershift experiments. (E) Differential binding of PBj-wt and PBj-Nef202/203GG Nef to cellular signaling proteins. GST-PBj-Nef fusion
proteins were used to precipitate potential binding partners from lysates of non-stimulated T cells. Precipitates were analyzed for Raf-1, ERK-2
and p56
lck by Western Blot. Precipitations with GST, Protein A-coupled anti-Raf-1, and total cell lysates (TCL) served as controls.
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ber of signaling pathways, including interaction with the T
cell specific kinase p56
lck [49], we analyzed functionality of
both GST-Nef proteins by co-precipitation of p56
lck.A s
expected, p56
lck co-precipitated with GST-Nef-PBj-wt and
GST-PBj-Nef202/203GG in similar amounts (Figure 2E,
lower).
Nef202/203GG retains certain Nef functions, but reveals
impaired capacity to downmodulate CD4, CD28, or CD3
No structural implications for the folding of the Nef pro-
tein should be expected since these mutations are located
in an external loop region of Nef (personal communication,
B. Stauch, EMBL Heidelberg, Germany). Nevertheless,
we confirmed typical Nef-associated properties and
functions besides the preserved interaction with p56
lck
(Figure 2E), which are not related to the ERK-mediated
effects of the Nef202/203GG mutant. To analyze the func-
tional activity of the mutated Nef protein, we first deter-
mined its ability to suppress NF-AT activation in A3.01 T
cells [33,34]. We found that both the wt and the 202/
203GG mutant Nef inhibited NF-AT induction by about a
5-fold downmodulation (Figure 3A), consistent with the
published data for other SIV Nefs’ [34]. GST-pulldown
experiments further indicated structural integrity of the
Nef202/203GG mutant protein by the association of
g-adaptin of the AP-1 adaptorprotein complex to both
Nef-PBj-wt and Nef202/203GG (Figure 3B).
Figure 3 Analysis of Nef functions. (A) Analysis of NF-AT-activity. A.301 cells were co-transfected with a NF-AT-Luc-reporter plasmid and
expression plasmids containing PBj-nef-wt, PBj-nef-202/20GG or pGL3-Basic as control. 16 h prior lysis, cells were stimulated with TPA and
ionomycin (white bars) or solvent control (black bars). Mean of results of dual luciferase assays in triplicates is shown as relative luciferase units
(RLU) (**, P < 0.04 compared to control; ns, P > 0.25). (B) Binding of the Golgi adaptor complex AP-1. GST-fusion proteins containing the C-
terminal part (aa109-261) of PBj-wt and PBj-Nef202/203GG Nef was used to precipitate AP-1 from lysates of non-stimulated T cells, and GST
served as control. Precipitates were analyzed by Western Blot using an AP-1 g-subunit (g-adaptin) detecting antibody (upper panel) or GST
detecting antibody (lower panel). (C) Downmodulation of cell surface receptors. Analysis of Nef mediated downmodulation of CD3, CD4, CD28
and MHC-I was done and related to GFP reporter expression in Jurkat T cells transfected with respective pCG-nef-IRES-GFP plasmids as analyzed
by FACS. For quantification, the levels of specific surface molecules´ expression (red fluorescence) were determined for cells expressing a specific
range of GFP (n, no; l, low; m, medium; h, high expression). The extent of downmodulation (x-fold) was calculated by dividing the MFI obtained
for cells transfected with the nef-minus plasmids by the corresponding values obtained for cells transfected with plasmids coexpressing Nef and
GFP (NC, no Nef; SIVmac239, Nef of SIVmac239; PBj-wt, wt Nef of PBj; PBj-mut, Nef202/203GG of PBj). One representative out of 3 experiments
displayed.
Tschulena et al. Retrovirology 2011, 8:14
http://www.retrovirology.com/content/8/1/14
Page 6 of 17We next analyzed the surface expression of CD4, CD3,
CD28 or MHC-I molecules on T cells transfected with
pCG vector constructs expressing the wt-Nef, Nef202/
203GG or, as positive control for downmodulation, Nef
of SIVmac239, As expected, SIVmac239 Nef strongly
downmodulated CD4, CD3, CD28 and MHC-I mole-
cules. Interestingly, MHC-I was neither down regulated
by wt or mutated PBj Nef (Figure 3C). As expected
from previous studies [37,50], Nef202/203GG was atte-
nuated in down-modulation of CD3 and defective in
CD4 (Figure 3C), as well as CD28 down-modulation.
The latter was expected, since the D-D-X-X-X-E motif
in HIV-1 Nef has been recently described to be a novel
AP-2 binding domain [51] and mediates contact of Nef
to the V1H subunit of the vacuolar ATPase, which is
most likely implicated in CD4 and CD28 down-modula-
tion, as well [52,53].
These in vitro results show that Nef202/203GG
enhances viral replication in the absence of mitogenic
signaling and CD4 down-modulation and indicate struc-
tural integrity and function of Nef202/203GG.
PBj-Nef202/203GG does not induce secretion of IL-2 in
non-stimulated PBMCs
Cell proliferation and activation of ERK1/2 are impor-
tant for induction of cellular responses such as the
expression of cellular activation markers CD25 or secre-
tion of IL-2. In infected non-stimulated PBMCs, flow
cytometric analysis revealed that at day 10 p.i. a signifi-
cantly higher proportion of CD25-positive cells was pre-
sent in PBj-wt- as compared to PBj-Nef202/203GG
virus infected PBMCs (62% vs. 38%, respectively) (Figure
4A and 4B). Furthermore, PBj-wt-infected non-stimu-
lated PBMCs of 3 different donors on average secreted
267 pg/ml IL-2 as determined by ELISA, whereas PBj-
Nef202/203GG-infected non-stimulated PBMCs did not
secrete detectable amounts of IL-2 (Figure 4C). Remark-
ably, non-stimulated PBMCs infected with PBj-wt or
PBj-Nef202/203GG both secreted comparable levels of
IL-6 accumulating to approximately 90 U/ml at day 2 p.
i. (Figure 4D).
Taken together, these data show that the D-D-X-X-X-
E motif in PBj-Nef is required for induction of cell
Figure 4 Activation of infected macaque PBMCs in vitro. Non-stimulated macaque PBMCs were infected with PBj-wt or PBj-Nef202/203GG
virus. (A and B) FACS analysis of cell surface expression of T cell activation marker CD25 on day 10 p.i. (A) Histograms of one representative
animal. (B) Scattergram of CD25 surface expression on T cells of 4 different animals, horizontal bars represent means (**, P < 0.04; ***, P < 0.001).
(C) IL-2 concentration and (D) IL-6 concentration was measured in tissue culture supernatants of infected PBMCs of 3 different animals by ELISA.
Error bars, SD.
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ing pathway and NF-B, expression of cell surface acti-
vation markers CD25, and IL-2 secretion in infected
PBMCs.
Efficient replication of PBj-wt and PBj-Nef202/203GG in
vivo
After thorough analysis of mutated PBj virus in vitro,w e
aimed to analyze the effects of the Nef203/203GG muta-
tion in vivo. Therefore, four pig-tailed macaques were
infected intravenously (i.v.), three of them (animals #267,
#275, #276) with 5 × 10
5, and one (animal #277) with 5 ×
10
6 infectious units (TCID50) of PBj-Nef202/203GG
virus. In parallel, two macaques (#250, #6504) were
infected with 6 × 10
5 and one (#260) with 6 × 10
6 infec-
tious units (TCID50) of PBj-wt virus (Table 1). Blood
samples of all animals were analyzed for cell-associated
viral load, plasma viremia and lymphocyte numbers at
different time-points p.i. We verified that the sequences
encoding either the wild type or the mutated D-D-X-X-
X-E motif were not mutated on day 9 p.i. from plasma-
derived viral RNA from 10 sequenced independent iso-
lated sequences (data not shown). Inoculated animals dis-
played a rapid rise in cell-associated viral load with
maximal viral load at day 9 to 12 p.i. (Figure 5A and 5B)
and PBj-wt- (Figure 5A) and PBj-Nef202/203GG-virus
infected (Figure 5B) macaques showed comparable cell-
associated viral load at all time points analyzed.
Plasma viremia was determined by quantitative RT-
PCR measuring viral genome copy numbers in the
plasma. All animals inoculated with 5 × 10
5 TCID50 of
either virus and animal #277, being inoculated with the
10-fold higher dose of PBj-Nef202/203GG virus,
revealed similar plasma viral load around 10
4 RNA
copies / ml on day 5 p.i. (Figure 5C and 5D). Animals
inoculated with PBj-Nef202/203GG virus plateau on this
level of plasma viremia showed mean titers of about 10
5
RNA copies / ml (Figure 5D), whereas macaques #250
and #6504 inoculated with PBj-wt virus displayed a
further rise in plasma viral load titers up to 10
7 RNA
copies / ml around day 8 p.i. (Figure 5C). Animal #260,
inoculated with a 10-fold higher dose of PBj-wt virus,
revealed increased replication kinetics achieving already
on day 5 p.i. 10
7 RNA copies / ml plasma.
Following infection with PBj-wt virus, circulating
numbers of lymphocytes dropped to an average of 25%
of pre-inoculation values around day 8 p.i. (Figure 5E).
In macaque #250, which survived the acute phase of dis-
ease, circulating lymphocyte numbers rebounded to
above pre-inoculation values on day 12 p.i. Three of the
four PBj-Nef202/203GG-infected macaques showed a
decrease in the number of circulating lymphocytes to an
average of 54% of pre-inoculation values and one ani-
mal, macaque #276, infected with the lower dose of PBj-
Nef202/203GG virus, did not develop lymphopenia
(Figure 5F). Replication of both PBj-wt virus and
PBj-Nef202/203GG virus in vivo was followed by analy-
sis of anti-SIV antibody induction. All animals tested
had been seronegative up to day 8 p.i., as expected
(Figure 5G). The animals surviving the acute phase of
infection (#250, #275, and #276) revealed seroconversion
by day 27 p.i. (Figure 5G), irrespective of the inoculated
virus. Overall, these results indicate that mutation of the
D-D-X-X-X-E motif does not abrogate the efficiency of
virus replication.
PBj-Nef202/203GG virus does not induce an acute lethal
enteropathic disease in infected pig-tailed macaques
All animals infected with PBj-wt virus developed a typi-
cal SIVsmmPBj-associated pathogenesis with character-
istic fulminant disease symptoms including hemorrhagic
diarrhea, anorexia, exicosis, apathy and rash, which were
most severe between day 7 to 9 p.i. (Table 1). Macaque
#260, which was infected with a higher dose of PBj-wt
virus, developed massive acute disease symptoms at day
5 p.i. and succumbed to disease on day 7 p.i. PBj-wt
virus infected macaque #6504 was euthanized on day 8
p.i., when showing comparable severe clinical symptoms.
Subsequent complete histopathological analysis of
spleen, liver, gut, and different lymph nodes revealed
major pathological changes in the PBj-wt virus infected
macaques #260 and #6540 as compared to a healthy
Table 1 Clinical symptoms observed after inoculation of macaques with different doses of PBj-wt or PBj-Nef202/
203GG virus
Virus Macaque Dose (TCID50) Anorexia Dehydration Haemor. Diarrhea Apathy Rash
PBj-wt #260 5 × 10
6 ++ + + -
#250 5 × 10
5 ++ + + +
#6504 5 × 10
5 ++ + + -
PBj-
Nef 202/203GG
#277 5 × 10
6 -- - - -
#267 5 × 10
5 -- - - -
#275 5 × 10
5 -- - - -
#276 5 × 10
5 -- - - -
Occurrence of symptoms is indicated by “+”, absence by “-”.
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Page 8 of 17Figure 5 Kinetics of plasma viremia and lymphopenia and seroconversion in macaques inoculated intravenously with PBj-wt or PBj-
Nef202/203GG. After inoculation of pig-tailed macaques with PBj-wt or PBj-Nef202/203GG virus blood samples were taken at different time-
points p.i. and analyzed for cell associated viral load and relative lymphocyte counts. Data for animals #260 and #277, inoculated with the 10-fold
virus dose, are shown in grey. (A and B) Cell associated viral load in the peripheral blood, determined by limiting dilution titration of PBMCs of
infected macaques on C8166 cells, presented as TCID50 for animals inoculated with (A) PBj-wt virus or (B) PBj-Nef202/203GG. (C and D) Plasma
viral load determined by quantitative RT-PCR on plasma of infected macaques, presented as genome copies / ml plasma for animals inoculated
with (C) PBj-wt virus or (D) PBj-Nef202/203GG. (E and F) Total lymphocyte counts of infected macaques, related to preinoculation values. (G)
Seroconversion of infected animals, as determined by crossreactive anti-HIV ELISA and shown as sample to cut-off value (S/CO). CO is indicated
by dotted line.
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trointestinal tract (Figure 6A), where blunting and
fusion of intestinal villi, massive infiltration of lymphoid
cells into the lamina propria (Figure 6B), and a massive
hyperplasia of spleen and lymph nodes were observed.
In contrast to the animals infected with PBj-wt virus,
none of the macaques infected with the mutant virus
PBj-Nef202/203GG showed any of the clinical symptoms
described above. Animals #277 and #267 were sacrificed
on day 8 p.i. and showed a mild hyperplasia of spleen
and lymph nodes, which was much less profound than
in PBj-wt virus infected macaques. No macroscopical
changes or lesions were found in the gastrointestinal
tract (Figure 6A). Detailed histopathological analysis
revealed minor fusions of intestinal villi and moderate
numbers of lymphocytes in the lamina propria and the
GALT (Figure 6B). Thus, these data indicate that the
presence of the D-D-X-X-X-E motif in PBj-Nef is
required for the induction of acute lethal pathogenicity
in infected pig-tailed macaques.
PBj-Nef202/203GG virus infected pig-tailed macaques
showed reduced cytokine secretion and expression of
activation markers on CD3
+ T cells
In vitro studies described above suggested a role of the
D-D-X-X-X-E motif in the release of cytokines. There-
fore, the concentrations of IL-2 and IL-6 in the serum
of inoculated animals were quantified by ELISA at dif-
ferent time-points p.i. All PBj-wt virus inoculated ani-
mals showed elevated IL-2 levels in the serum with a
peak between day 7 and 9 p.i. (Figure 7A). The ani-
mals infected with the lower dose of PBj-wt virus
revealed IL-2 serum levels of up to 16.1 pg/ml (maca-
que #6504) and 6.5 pg/ml (macaque #250). In the
serum of macaque #260, infected with the higher dose
of PBj-wt virus, 130.6 pg/ml IL-2 were measured at
day 7 p.i. This indicates that the amount of IL-2
secretion might be dose-dependent. Animals inocu-
lated with PBj-wt virus showed IL-6 serum levels of
1.0 (macaque #250), 6.0 (macaque #6504) and 76.8 U/
ml (macaque #260), respectively (Figure 7B). In
Figure 6 Representative histopathology of infected macaques at day 8 p.i. (A) Macroscopic pictures of the colon of PBj-wt virus infected
macaque #6504 and PBj-Nef202/203GG virus infected macaque #267. One characteristic ulcerative-necrotic lesion is indicated by an arrow. Scale
bar, 1 cm. (B) Colon tissue sections stained with hematoxylin and eosin. PBj-wt virus infected macaque #6504 showed blunting and fusion of
intestinal microvilli, resulting in complete loss of tissue structure, accompanied by massive infiltration of lymphocytes into the lamina propria.
Macaque #267 showed intact microvilli architecture and moderate infiltration of lymphocytes. Scale bar, 100 μm.
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infected macaques revealed detectable serum levels of
IL-2 or IL-6 (Figure 7A and 7B).
As described, we observed different cell activation by
PBj-wt and PBj-Nef202/203GG virus in vitro.T h e r e f o r e ,
we determined the effect of the D-D-X-X-X-E motif on T
cell activation in vivo. By FACS analysis, the expression of
the early and late activation markers CD69 and CD25 was
determined on T cells isolated from peripheral blood of
infected animals. On the peak day of symptoms (day 7/8),
an average of 14.7% of CD3
+CD8
+ peripheral T cells
expressed CD69 in PBj-wt virus inoculated macaques
Figure 7 Kinetics of plasma cytokine levels and activation markers on T cells of infected macaques in vivo. (A and B) Serum levels of (A)
IL-2 and (B) IL-6 in blood samples taken at different time-points p.i., determined by monkey IL-2 and IL-6 ELISA, respectively. (C to F) Analysis of
cellular activation markers on T cells at peak day of symptoms (day 8 p.i.) was determined by FACS. Percentage of positive cells is indicated. (C)
Fraction of CD69 expressing CD3
+CD8
+ T cells in the peripheral blood of PBj-wt or PBj-Nef202/203GG virus infected or uninfected macaques.
Scattergram of individual animals, horizontal bars represents means. (D and E) CD69 surface expression on CD3
+ T cells from lymphatic organs
(mesenterial lymphnodes, LN mes; spleen) of PBj-wt virus infected macaque #6504 and PBj-Nef202/203GG virus infected macaque #267. (D) Dot
blot FACS analysis of representative individuals. (E) CD69 determined on CD3
+CD8
+ gated lymphocytes. (F) CD25 on CD3
+CD4
+ cells from LN
mes and spleen of infected macaques.
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macaques and 1.9% in non-infected macaques (Figure 7C).
Since the majority of activated T cells migrate to lym-
phatic organs, we analyzed activation of T cells in these
tissues. In spleen and mesenterial lymph nodes (LN
mes) of PBj-wt virus infected macaque #6504, a higher
fraction of CD3
+CD8
+CD69
+ and CD3
+CD4
+CD25
+ T
cells was found on day 8 p.i., as compared to PBj-
Nef202/203GG virus infected macaque #267 (Figure 7D
to F). The differences were most profound in the spleen
represented by 51% CD3
+CD8
+CD69
+ spleenocytes in
PBj-wt virus- compared to 18% in PBj-Nef202/203GG
virus-infected animals, respectively. Thus, the ability of
PBj-wt virus to stimulate T cells in vivo was diminished
by mutation of the D-D-X-X-X-E motif within Nef, con-
firming the results obtained in vitro. Taken together, our
data reveal that the D-D-X-X-X-E motif is important for
both CD3
+ T cell activation as well as induction of IL-2
and IL-6 secretion in vivo. The activation status of T-
cells in the GALT and the ability of the virus to induce
secretion of these cytokines seem to be critical for the
induction of enteropathy and the acute lethal
SIVsmmPBj phenotype.
Discussion
Ongoing and high levels of immune activation is
regarded as a hallmark of pathogenic SIV and HIV infec-
tions during the chronic phase of infection [54,55]. To
evaluate the impact of the ability of a lentivirus to cause
T cell activation and cellular proliferation on the induc-
tion of disease, this study examined the pathophysiologi-
cal consequence of two adjacent aspartate to glycine
mutations within the conserved D202-D203-X-X-X-E
motif in the C-terminal region of SIVsmmPBj-Nef. Infec-
tion of macaque PBMCs with PBj-wt virus induced acti-
vation of the Raf-MEK-ERK signaling pathway, activation
of NF-B, cell proliferation, expression of T cell surface
activation markers and IL-2 secretion in vitro.T h e
mutant virus PBj-Nef202/203GG failed to induce these
physiological activities despite of displaying similar repli-
cation kinetics, the same level of Nef protein expression
and conservation of inhibition of the induction of NF-AT
activity as observed for the wild-type virus or protein.
Moreover, the mutant virus lost its ability to down-mod-
ulate CD4 and CD28 and impaired the down-modulation
of CD3 on infected T cells. These data indicate that the
ability of SIVsmmPBj to replicate in non-stimulated, rest-
ing PBMCs is not dependent on the observed cellular
responses associated with virus infection, which were lost
in the PBj-Nef202/203GG virus.
As expected, infection of pig-tailed macaques with
PBj-wt virus led to development of the characteristic
acute enteropathic disease, accompanied by T cell acti-
vation as well as elevated IL-2 and IL-6 serum levels. In
contrast, the PBj-Nef202/203GG virus neither induced
acute enteropathic disease nor comparable T cell activa-
tion in infected animals, although efficient viral replica-
tion of the mutant was observed in vivo. In summary,
the in vivo studies strongly indicate a selective role of
the diacidic motif in T cell hyperactivation and entero-
pathic disease but not in virus replication.
Cell proliferation, activation of ERK1/2 and NF-B,
and secretion of IL-2 observed after PBj-wt virus infec-
tion in vitro seem to be mediated by interplay of Nef
with the mitogenic signaling cascade involving the D-D-
X-X-X-E motif. Hodge and coworkers demonstrated a
direct interaction of Raf-1 and Nef of HIV-1 through
this conserved motif [40]. In the present study, we con-
firmed the interaction of Raf-1 also with PBj-Nef, but in
contrast to HIV-1-Nef, the interaction was not abolished
by the two point mutations in the D-D-X-X-X-E motif.
However, we detected a notable difference of wild-type
PBj-Nef and mutant Nef protein in their capacity to
recruit ERK-2 kinase into the Nef-associated signaling
complex. Compared to wild-type PBj-Nef, a strong
impairment of ERK-2 association with Nef202/203GG
was observed that might be associated with the differen-
tial capacity to activate ERK. Most likely, the observed
differences in IL-2 secretion, induction of CD69 surface
expression, and NF-B activation can be attributed to
impaired ERK activation, as these cellular responses
have been shown to be activated by the mitogenic sig-
naling cascade [42,44,45,56]. However, we cannot con-
clude that the physiological effects of Nef are visible in
infected cells, only. In contrast, a bystander effect might
be also expected in uninfected cells due to the enhanced
stimulatory cytokine secretion of infected cells and sti-
mulation of uninfected cells, thereby. Moreover, other
pathways might be also involved in the reported pheno-
typic differences between wild-type PBj-Nef and the
mutant Nef protein, since the D-D-X-X-X-E motif has
also been reported to be involved in interaction with
AP-2 and V1H-ATPase [51-53,57]. Accordingly, our
results confirm that mutation of the D-D-X-X-X-E
motif is affecting the capacity of Nef to down-modulate
especially CD4 [37,57] and CD28, using the AP-2
mediated pathway [58]. Interestingly, Nef202/203GG
was still able to down-modulate CD3, albeit at lower
efficiency (Figure 3D). The surface expression levels of
CD4, CD3, CD28 or MHC-I molecules on T cells is
affected by the endocytotic recycling pathway of cellular
surface molecules. The regulation of these pathways is
described to be associated to ERK-signaling [59]. Thus,
a non-mutually exclusive additional effect of the intro-
duced Nef mutations on the CD4, CD3, and CD28 sur-
face expression levels mediated via the MAP kinase ERK
signaling pathways is possible and might also alter
pathogenesis in vivo.
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features in respect to mitogenic signaling and kinase
activation most likely due to the presence of the ITAM
motif in PBj-Nef, which may result in CD3/CD28 co-sti-
mulus independency. The ITAM is a critical component
of the CD3-induced T cell signaling pathway, known to
activate cells via the Raf/MEK/ERK signaling cascade. It
has already been demonstrated that mutations in the
ITAM of PBj-Nef reduced acute pathogenicity [30].
Moreover, introduction of the ITAM into the Nef pro-
tein of the pathogenic SIV strain SIVmac239 by a single
point mutation has resulted in a virus mutant displaying
similar characteristics as SIVsmmPBj in vitro and in
vivo [27-29]. Interestingly, an inactivation of the D-D-X-
X-X-E motif in Nef of the already mentioned SIV-
mac239 leads to attenuation of pathogenicity and viral
replication in macaques [50]. This observation has been
linked to the loss of downmodulation of CD4 on
infected cells by the respective virus mutant [50].
Most importantly, we exploited the unusual phenotype
of the SIVsmmPBj model in triggering T cell activation
to investigate the relative contribution of virally induced
T cell activation on the pathogenic potential of a lenti-
virus. Although a reduction in RNA viral loads is
observed in PBj-Nef202/203GG infected animals at 8 d.
p.i., this may not exclusively be causative for the
observed dramatic differences in pathogenicity. Cummu-
lating evidence suggests that viral replication alone is
not sufficient to cause disease. It has been demonstrated
that general T cell activation is a better predictor of
AIDS progression than viral loads [60,61]. Furthermore,
absence of chronic immune activation, despite robust
viral replication, is a common feature of asymptomatic
natural infections with SIVsm and SIVagm [9,10]. Inter-
estingly, experimental induction of immune activation in
chronically SIVagm-infected African green monkeys has
recently been reported to result in increased viral repli-
cation and CD4
+ T cell depletion [62]. On the other
hand, re-inoculation of sooty mangabey monkeys with
the pathogenic SIVmac239 strain that causes simian
AIDS in rhesus macaques results in an asymptomatic
course of infection [63].
It is conceivable that viral as well as host factors
impact the course of infection and therefore the induc-
tion of disease. However, it is still unclear which deter-
minants drive the chronic immune activation
associated with disease progression. It has been pro-
p o s e dt h a tm i c r o b i a lt r a n s l ocation caused by depletion
of the GALT during the acute phase is a cause of sys-
temic immune activation in progressive disease [11,12].
However, recent data show that depletion of the
GALT is a common feature of symptomatic as well as
asymptomatic courses of infections [10]. Remarkably,
microbial translocation and destruction of the mucosal
barrier did only occur in pathogenic lentiviral infec-
tions [10,11,64]. Thus, maintenance of the mucosal
barrier is generally considered to be a host specific fea-
ture. Here, it is noteworthy that pig-tailed macaque
already display a compromised gastrointestinal integ-
rity on the microscopic level already in the absence of
SIV infection, which is potentially explaining on the
one hand the more rapid disease progression of SIV
infected pig-tailed macaques to simian AIDS [65], and
on the other hand the higher pathogenicity of
SIVsmmPBj induced acute disease in pig-tailed maca-
ques [66] as opposed to rhesus macaques.
The data presented herein demonstrate that subtle
alterations affecting the ability of a lentivirus to cause T
cell activation can have a dramatic impact on disease
progression and the integrity of the mucosal barrier.
Previously it has been suggested that HIV-1 is particu-
larly pathogenic in humans because its Nef is unable to
suppress CD3 and consequently T cell activation [33].
This hypothesis is supported by recent data showing
that the ability of Nef to block T cell activation corre-
lates with preserved CD4 counts in naturally infected
sooty mangabeys [34]. The phenotype of the PBj-
Nef202/203GG virus in pig-tailed macaques resembles
the situation of asymptomatic SIV infections of sooty
mangabeys or African green monkeys: robust viral repli-
cation and macroscopically largely intact mucosal bar-
rier in the absence of chronic immune activation. This
is even more remarkable in the light of the described
compromised gastrointestinal integrity of pig-tailed
macaques [65]. It is furthermore noteworthy that this
phenotype was achieved by the sole alteration of two
amino acids in Nef lowering mitogenic signaling in the
infected cell.
Therefore, our results demonstrate that high levels of
general immune activation and integrity of the mucosal
barrier in response to a lentiviral infection are not
exclusively inherent features of the host. Rather than
this, subtle alterations in the ability of a lentivirus to
cause T cell activation can have a dramatic impact on
disease progression.
Conclusions
The mutation of a conserved diacidic motif in the Nef
protein of the SIVsmm strain PBj is sufficient to pre-
vent acute lethal disease in pig-tailed macaques despite
efficient replication in vitro and in vivo. This attenu-
ated phenotype is paralleled by modified mitogenic sig-
nalling in infected PBMCs. These data reveal that an
ITAM motif found in the Nef protein of this SIV
strain has to work in tandem with the conserved diaci-
dic motif of Nef in activation of immune cells and
concomitant pathogenicity, suggesting a potential role
of the latter motif for the pathogenic potential of
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changes affect the ability of a lentivirus to cause T cell
activation and can have a dramatic impact on the
respective viral pathogenic potential.
Moreover, the absence of high levels of immune acti-
vation in vivo in response to efficient infection by the
mutant virus reveals that the extent of immune activa-
tion in infected animals in response to lentiviral infec-
tion is not exclusively linked to host species-specific
factors, but also determined by virus-specific features.
Thus, our data suggest that specific features of lenti-
viruses may have a profound impact on disease outcome
of different species, allowing potential interference
within the virus-host interplay in the establishment of
pathogenic infections.
Methods
Cells
Primary macaque PBMCs were isolated by Histopaque
Ficoll (Sigma, Taufkirchen, Germany) gradient centrifu-
gation from peripheral blood of M. nemestrina.P B M C s
used for subsequent in vitro assays and human C8166
cells (ECACC No. 88051601) were cultured in RPMI
1640 supplemented with 2 mM L-Glutamin, 10% FCS
and antibiotics.
Plasmids and virus
For generation of Nef-mutated SIVsmmPBj, plasmid
pPBj1.9 encoding the infectious molecular clone
SIVsmmPBj1.9 [15] was digested with EcoRI/NotI. The
resulting 2,432 bp fragment was subcloned into the plas-
mid pZeoSV2+. Site-directed mutagenesis of the nef
gene was performed using the QuickChange Kit (Strata-
gene, La Jolla, USA) according to the manufacturer’s
protocol using forward (5’-ACAAACTTCTCAGT
GGGGTGGCCCCTGGGGAGAGGTACTGGC-3’)a n d
reverse (5’-GCCAGTACCTCTCCCCAGGGGCCACCC
CACTGAGAAGTTTGT-3’) primers carrying two cen-
tral single nucleotides (bold) resulting in the mutation
of the encoded aspartate residues 202/203 into glycines
(underlined) of the nef gene. The mutated plasmid DNA
was verified by sequencing. Subsequently, the mutated
subfragment was cloned back into pPBj1.9 via EcoRI/
NotI, yielding the plasmid pPBj1.9Nef202/203GG. To
generate expression plasmids (pGEX6P-PBjNefwt /
-PBjNefGG) for PBj-wt and GST PBj-Nef202/203GG
Nef-glutathione S-transferase (GST) fusion proteins,
respectively, the respective nef genes were cloned into
the plasmid pGEX-6P2 (Pharmacia, Uppsala, Sweden)
according to the manufacturer’si n s t r u c t i o n sb yP C R
using forward primer (5’-CGGGATCCGGTGGCGTTA
CCTCCAAGAAG-3’) and reverse primer (5’-CCGG
AATTCTTAGCTTGTTTTCTTCTTGTCAGCC-3’).
Wild-type or mutant virus was produced by transfect-
ing pPBj1.9 or pPBj1.9Nef202/203GG plasmid DNA into
human C8166 T cells using DMRIE-C (Invitrogen, Karls-
ruhe, Germany) according to the manufacturer’sp r o t o -
col. Supernatant was harvested 8 days after transfection
and virus samples were stored at -80°C. The 50% tissue
culture infectious dose (TCID50) was determined by lim-
iting dilution infectivity titration into C8166 T cells.
Animal experiments
Animal studies on pig-tailed macaques (Macaca nemes-
trina) were performed in accordance with the guidelines
o f§ 8A b s . 1o ft h e“Deutsches Tierschutzgesetz”
(TierSchG, BGB1.1 S.1105). The animals were SIV-nega-
tive and free of concurrent infections. For infections,
macaques were inoculated i.v. with 5 ml PBS containing
either 5 × 10
5 or 5 × 10
6 TCID50 of PBj-wt or PBj-Nef202/
203GG virus. Citrate-buffered anti-coagulated blood sam-
ples were collected on days 0, 5, 7, 9, 12 and 27 post
inoculation as well as on the days the animals were sacri-
ficed by i.v. injection of 5 - 10 ml of T61 (Intervet
Deutschland GmbH, Unterschleissheim, Germany).
Virus load, lymphocyte counts and tissue analysis
Cell associated virus load (TCID50) in the peripheral
blood of infected macaques was determined by limiting
dilution infectivity titration of PBMC into C8166 T
cells. Plasma viremia was quantified by quantitative RT-
PCR. For this purpose, viral RNA was isolated from
plasma samples using the QIAamp viral RNA extraction
Kit (Qiagen, Hilden, Germany) according to the manu-
facturer’s instructions. Copy numbers of viral genomes
were quantified utilizing the QuantiFast SYBR Green
RT-PCR Kit (Qiagen) with the primer pair SIV_F02 (5´-
GCAAATCCAGATGTGACCCT-3´) and SIV_R02 (5´-
GGTGGGCCACAATTCATATC-3´) on a LightCycler
Instrument (Roche Diagnostics, Mannheim, Germany)
according to manufacturers´ instructions with an
annealing/extension temperature of 62°C. Hematology,
particularly determination of lymphocyte numbers, was
performed with an automated hematology analyzer
(Cell-Dyn 3500SL, Abbott Diagnostics, Santa Clara,
USA). Complete pathohistological examination of sacri-
ficed animals was performed using haematoxylin and
eosin (H&E) staining according to standard protocols.
ELISAs and RT activity test
For determination of interleukin (IL)-2 and IL-6 levels
in cell culture supernatants and serum samples, monkey
IL-2 and IL-6 ELISAs (Biosource, Nivelles, Belgium)
were performed according to the manufacturer’sp r o t o -
col. To determine reverse transcriptase (RT) activity
from cell culture supernatants, the Lenti RT Activity Kit
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manufacturer’s directions.
Flow cytometry
FACS analysis was performed from EDTA anti-coagu-
lated blood samples using the Immunoprep kit (Beck-
m a nC o u l t e r ,F u l l e r t o n ,U S A )a c c o r d i n gt ot h e
manufacturer’s protocol. Samples were incubated for 30
min with fluorophor-conjugated a-CD3-FITC, a-CD4-
PE, a-CD8-PerCP, a-CD69-PE, or a-CD25-PE mono-
clonal antibodies (BD Bioscience, Franklin Lake, USA)
and analyzed with a FACScan cytometer (BD
Bioscience). Only living cells were gated and analyzed.
Proliferation assay
3×1 0
5 macaque PBMC were infected with an MOI of 1
and were labelled on day 10 p.i. with 1 μCi of [
3H]-thy-
midine (GE Healthcare, Buckinghamshire, UK) for 18 h.
[
3H]-Thymidine incorporation was assessed using a
Betaplate scintillation counter (Perkin-Elmer, Turku,
Finland).
In situ immunostaining
3×1 0
5 macaque PBMC were infected with an MOI of
1. After attaching cells to poly-L-lysin-coated plates
(Sigma) and fixation with methanol at -20°C, infected
cells were visualized by IPA-staining of viral proteins as
described previously [67].
Western blot analysis
SIVsmmPBj1.9 Nef was detected in lysates of uninfected,
PBj-wt or PBj-Nef202/203GG virus-infected C8166 T
cells or macaque PBMC by Western blot analysis using
crossreacting anti-HIV-2 Nef rat monoclonal antibody
Hom-HB5 as described previously [46,67]. Subsequently,
the blot was reprobed using anti-SIV-Gag p27 (clone
K K 6 0 ,N I B S C ,H e r t f o r d s h i r e ,U K ) ,a n t i - H I V - 2 - V p x
(clone 6D2.6, NIH AIDS Research and Reference
Reagent Program, Rockville, USA), anti-SIV-Vpr (kindly
provided by B. Hahn) and anti-tubulin (clone YL1/2,
Abcam, Cambridge, UK).
Kinase phosphorylation assay
For kinase assays, supernatants of macaque PBMC
lysates were prepared and incubated with polyclonal
rabbit anti-ERK1/2 antibodies (Santa Cruz Biotechnol-
ogy, Santa Cruz, USA) followed by incubation with pro-
tein A agarose and precipitation, as described previously
[68]. Precipitates were washed in lysis and kinase buffer
as described [46], incubated in kinase buffer supplemen-
ted with 5 μCi of [g-
32P]ATP (GE Healthcare, Buckin-
ghamshire, UK ) and 1 μgE l k - 1s u b s t r a t e( C e l l
Signaling Technology; Danvers, USA) for 15 min at 30°
C. After termination of the reaction in sample buffer,
samples were subjected to SDS-PAGE, electroblotted
and analyzed by autoradiography.
Electrophoretic mobility shift assay (EMSA)
EMSA was done as described [69] with modifications. In
brief, equal amounts of uninfected, PBj-wt or PBj-
Nef202/203GG virus-infected macaque PBMC were
lysed by repeated freeze-thaw cycles on ice. For binding
reactions, 3 - 5 μg samples of nuclear extracts were
incubated at room temperature for 20 min in the pre-
sence or absence of unlabeled oligonucleotide or 1 μlo f
NF-B-p50 and NF-B-p65 specific antisera in a 20 μl
reaction mixture as described [46].
Luciferase assays for NF-AT-activities
For analysis of NF-AT activity, 0.5 μg of an NF-AT-luc
reporter (Stratagene) was cotransfected with 0.5 μgN e f
expression plasmids using a dual luciferase reporter sys-
tem for normalization (Promega). Cells were grown for
32 h and stimulated with TPA (20 ng/ml) and ionomy-
cin (5 μM) (both Calbiochem, Nottingham, UK) or incu-
bated with solvent for 16 h.
Assessment of downmodulation of CD3, CD4, CD28 and
MHC-I by Nef
Analysis of Nef mediated downmodulation of CD3,
CD4, CD28 and MHC-I was done as described else-
where [34]. Briefly, pCG-vector constructs, carrying
functional nef genes followed by an internal ribosome
e n t r ys i t e( I R E S )a n dt h eG F Pg e n ew e r ec l o n e da n d
used to transfect Jurkat T cells using the DMRIE-C
reagent as described [70,71]. CD4, CD3, MHC-I, CD28
cell surface expression and GFP reporter expression in
Jurkat T cells transfected with the respective pCG-con-
struct was analyzed by FACS. For quantification of Nef-
mediated modulation of specific surface molecules, the
levels of receptor expression (red fluorescence) were
determined for cells expressing a specific range of GFP.
The extent of downmodulation (x-fold) was calculated
by dividing the MFI obtained for cells transfected with
the nef-minus NL4-3 control by the corresponding
values obtained for cells transfected with vectors coex-
pressing Nef and GFP.
Precipitation with GST-PBj-Nef fusion proteins
GST-PBj-Nef fusion proteins were expressed in E. coli
using plasmids pGEX6P-PBjNefwt / -PBjNef202/203GG
and were purified according to manufacturer’si n s t r u c -
tions (Pharmacia). For precipitation, unstimulated T
cells were lysed in Triton-X100 lysis buffer. Superna-
tants of lysates were incubated with 100 μgf u s i o np r o -
tein or 2.5 μg anti-Raf-1 monoclonal antibody (BD
Biosciences) for 4 h at 4°C. Precipitation and Western
Blot analysis was performed as described [68] using
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(kindly provided by O. Janssen), and anti-g-adaptin ($$)
antibodies.
Statistics
All P-Values were calculated using the two-tailed Stu-
dent´s t-Test for heteroscedastic samples.
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